Delivery Order SPE2DB24D2106-SPE2DB24FAUNC

Award Date 7/16/24
Potential Completion Date 7/17/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,906.93, is for the delivery of 4564788297 ! YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product, with a completion date of June 4, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,916.25 firm fixed-price award is for the delivery of YUVAFEM 10 MCG vaginal inserts. The award is under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC vehicle, under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,813.40 delivery order is for the provision of YUVAFEM 10 MCG vaginal inserts. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue firm...
This federal contract award, valued at $9,104.55, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a delivery order under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the...
The federal contract award is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a ceiling value of $1,961.01 and a completion date of April 17, 2024. The contract is not set aside and is part of a larger $499,999,999...
This is a firm-fixed price delivery order for pharmaceutical products awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract award has a ceiling value of $1,627.06 and an ultimate completion date of July 15, 2024. DMS Pharmaceutical Group is the prime contractor and there is no set-aside designation mentioned. The contract provides a wide range of pharmaceutical items, including both...
This is a firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $9,948.88 and an ultimate completion date of April 2, 2024. The contract vehicle enables DLA to issue delivery orders against DMS Pharmaceutical Group's broader $4,999,999 indefinite delivery contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $12,508.77, covers the delivery of a range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military healthcare facilities nationwide. DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $17,614.47 contract is for the delivery of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities and VA medical centers nationwide. DMS...
This is a $7,013.28 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that allows the agency to issue orders for a wide range of pharmaceutical products. This delivery order is for the supply of various pharmaceutical items, including branded and generic prescription...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB24FAUNC
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,659.73 contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product. The contract has an ultimate completion date of July 17, 2024.

DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. This delivery order is part of that larger IDC vehicle, which does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 5/17/25, 9:52 AM